Stock-Based Compensation (Tables)

12 Months Ended

Oct. 28, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of reconciliation of the number of options outstanding and exercisable

A reconciliation of the number of options outstanding and exercisable (in thousands) as of October 28, 2018, and changes during the fiscal year then ended, is as follows: 

	Shares	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at October 29, 2017	30,685	$	18.08
Granted	6,272	36.39
Exercised	6,991	10.27
Forfeited	427	36.19
Expired	3	37.76
Outstanding at October 28, 2018	29,536	$	23.55	5.4	$	520,424
Exercisable at October 28, 2018	20,121	$	18.06	3.9	$	464,982

Schedule of weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised

The weighted-average grant date fair value of stock options granted, and the total intrinsic value of options exercised (in thousands) during each of the past three fiscal years is as follows: 

	Fiscal Year Ended
	October 28,		October 29,		October 30,
	2018		2017		2016
Weighted-average grant date fair value	$	7.16	$	6.41	$	7.82
Intrinsic value of exercised options	187,486		87,543		135,593

Schedule of weighted-average assumptions used to calculate fair value of each option award

The fair value of each option award is calculated on the date of grant using the Black-Scholes valuation model utilizing the following weighted-average assumptions:

	Fiscal Year Ended
	October 28,		October 29,		October 30,
	2018		2017		2016
Risk-free interest rate	2.7	%	2.4	%	2.1	%
Dividend yield	2.1	%	2.0	%	1.5	%
Stock price volatility	19.0	%	19.0	%	19.0	%
Expected option life	8 years		8 years		8 years

Schedule of reconciliation of the nonvested shares

A reconciliation of the restricted shares (in thousands) as of October 28, 2018, and changes during the fiscal year then ended, is as follows: 

	Shares	Weighted- Average Grant Date Fair Value
Restricted at October 29, 2017	58	$	35.62
Granted	52	34.08
Vested	57	35.62
Forfeited	1	35.62
Restricted at October 28, 2018	52	$	34.08

Schedule of the weighted-average grant date fair value of nonvested shares granted, the total fair value of nonvested shares granted, and the fair value of shares that have vested

The weighted-average grant date fair value of restricted shares granted, the total fair value (in thousands) of restricted shares granted, and the fair value (in thousands) of shares that have vested during each of the past three fiscal years is as follows: 

	Fiscal Year Ended
	October 28,		October 29,		October 30,
	2018		2017		2016
Weighted-average grant date fair value	$	34.08	$	35.62	$	41.01
Fair value of restricted shares granted	1,760		2,080		1,920
Fair value of shares vested	$	2,053	$	1,920	$	1,920

Schedule of stock-based compensation expense, along with the related income tax benefit

Stock-based compensation expense, along with the related income tax benefit, for each of the past three fiscal years is presented in the table below:

	Fiscal Year Ended
	October 28,			October 29,			October 30,
(in thousands)	2018			2017			2016
Stock-based compensation expense recognized	$	20,595		$	15,591		$	17,829
Income tax benefit recognized	(4,943		)	(5,879		)	(6,764		)
After-tax stock-based compensation expense	$	15,652		$	9,712		$	11,065